United States: FTC Weighs In On Orange Book Listing Of Drug-Device Patents - Jones Day
Mondaq
On March 22, 2024, the Federal Trade Commission filed an amicus brief in Teva Branded Pharmaceutical Products R&D, et al. v. Amneal..
On March 22, 2024, the Federal Trade Commission filed an amicus brief in Teva Branded Pharmaceutical Products R&D, et al. v. Amneal..
The Federal Trade Commission ("FTC") has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. Amneal..
We, Kangxin Partners, P.C., on behalf of client, TEVA PHARMACEUTICAL INDUSTRIES LIMITED, filed an opposition action against the..